Chat with us, powered by LiveChat
BUY TICKETS

SAVE $1026 BY DEC. 26

 Speaker Profile

Ph.D., Assistant Professor, Vanderbilt U. Medical Ctr.

Biography
Cathy Shyr is an assistant professor of biomedical informatics, pediatrics, and biostatistics at Vanderbilt University Medical Center. She received her PhD in biostatistics from Harvard University and is a statistical informatician specializing in machine learning (ML), AI, and causal inference methods for estimating personalized treatment effects. Her research focuses on the development and implementation of novel statistical ML and AI methods to advance precision medicine. Dr. Shyr leads the AI initiatives at the Vanderbilt Undiagnosed Diseases Network, developing and implementing large language models that leverage electronic health records data to accelerate rare disease diagnosis. She has developed methods that improve the generalizability of statistical ML and causal inference models across multiple heterogeneous datasets for estimating personalized risks and treatment effects. She is an active member of the All of Us Research Programs Data and Research Center, where she leads the development of AI tools supporting the return of study results.


Talk
Accelerating Rare Disease Diagnosis with Artificial Intelligence
This showcase highlights AI and statistical machine learning methods developed using real-world rare disease patient data at the Vanderbilt Undiagnosed Diseases Network to improve diagnostic accuracy and efficiency. These tools provide a scalable, reproducible framework for accelerating diagnoses for health systems evaluating undiagnosed patients with complex and rare conditions.


AI for Clinical Decision Support Systems Showcase:
Vanderbilt University Medical Center

Vanderbilt University Medical Center (VUMC) is a leading academic medical center and research institution known for its nationally recognized clinical programs, biomedical innovation, and translational science. VUMC integrates patient care, research, and education to advance precision medicine and improve health outcomes.

 Session Abstract – PMWC 2026 Silicon Valley

Showcase Track S1 - March 5 3.30 P.M.-1.30 P.M.,Showcase Track S1 - March 6 11.15 A.M.-11.15 A.M.


"The PMWC 2026 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative
"

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by DEC. 26TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required